|Bid||0.00 x 2900|
|Ask||0.00 x 800|
|Day's range||17.30 - 17.82|
|52-week range||12.86 - 23.01|
|PE ratio (TTM)||64.87|
|Earnings date||31 Jul 2018 - 6 Aug 2018|
|Forward dividend & yield||N/A (N/A)|
|1y target est||19.75|
On a per-share basis, the Bethlehem, Pennsylvania-based company said it had a loss of 3 cents. The diagnostic test maker posted revenue of $42 million in the period. For the current quarter ending in July, ...
On a per-share basis, the Bethlehem, Pennsylvania-based company said it had net income of 12 cents. The diagnostic test maker posted revenue of $52 million in the period. For the year, the company reported ...
While the world’s attention turns to Pennsylvania on February 2nd for Groundhog Day prognostications about winter weather, investment professionals will gather in Philadelphia a day early on February 1st for the 2018 Emerald Asset Management Groundhog Day Investment Forum.
Join Emerald Asset Management for the landmark 25th annual Emerald Groundhog Day Investment Forum on February 1st in Philadelphia. The Forum is the unofficial kick-off to the year
Orasure Technologies shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.
Orasure Technologies shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 70 to 83.
Edwards Lifesciences (EW) rides high on product launches as well as strength in the global Transcatheter Aortic Valve Replacement market.
After the completion of Shiel's acquisition, the medical lab is expected to expand Quest Diagnostics' (DGX) physician and patient service centers network in the New York-New Jersey area.